News Column

PROGENICS PHARMACEUTICALS INC FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

June 10, 2014

Item 8.01. Other Events.

Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today supplemented its April 29, 2014 definitive Proxy Statement previously furnished to stockholders in connection with its upcoming 2014 Annual Meeting of Stockholders to provide additional information in light of comments recently made by ISS Proxy Advisory Services.

A copy of Progenics' Supplement, which has been filed with the U.S. Securities and Exchange Commission and is being made available to stockholders at, is included in this Report as Exhibit 99.1. The Supplement should be read in conjunction with the Company's definitive Proxy Statement, which as so supplemented remains as described therein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Supplement, dated June 10, 2014, to Proxy Statement for 2014 Annual Meeting of Stockholders.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters